Cybersecurity

J&J top innovator at tail end of 2021

Nonetheless, research and innovation in cybersecurity in the medical sector has declined in the last year.

Powered by 

Johnson & Johnson was the top cybersecurity innovator in the medical sector in the last quarter. The company filed 45 related patents in the three months ending November. That said, that was down from 111 over the same period last year.

J&J was followed by Roche with 21 patent applications, Becton Dickinson (7 applications), and Illumina (6 applications).

Nonetheless, research and innovation in cybersecurity in the medical sector has declined in the last year.


The most recent figures show that the number of patent applications in the industry stood at 81 in the three months ending November - down from 137 over the same period last year.


Figures for patent grants related to followed a similar pattern to filings - shrinking from 89 in the three months ending November last year to 78 this year.


The figures are compiled by GlobalData, who track patent filings and grants from official offices around the world. Using textual analysis, as well as official patent classifications, these patents are grouped into key thematic areas, and linked to key companies across various industries.


Cybersecurity is one of the key areas tracked by GlobalData. It has been identified as being a key disruptive force facing companies in the coming years, and is one of the areas that companies investing resources in now are expected to reap rewards from.

Go to article: Home | Point-of-Care diagnosticsGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: PAMA Manufacturing and SterilizationGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: SartoriusGo to article: PicosunGo to article: CommentGo to article: No shortage of hurdles to overcome for implementation of IVDR in Europe for 2022Go to article: Orthopaedics trends: Tendon most mentioned term on Twitter Q4 2021Go to article: The growing elder population will continue to drive the global medical device maGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DepthGo to article: Patient advisors: could they change the face of medtech trials?Go to article: New UK medical device regulation spells potential trial concernsGo to article: Point-of-Care diagnostics: A boon awaits under remote healthcareGo to article: “Greener” choices in inhalers garner increasing pharma, device company supportGo to article: mdi ConsultantsGo to article: In DataGo to article: Artificial intelligence hiring in the medical industry rose in January 2022Go to article: J&J top innovator at tail end of 2021Go to article: January 2022 saw a 33% drop in medical devices’ approval in the USGo to article: EventsGo to article: Next Issue